107 related articles for article (PubMed ID: 21116565)
1. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM): its anti-cancer efficacy and intercalation mechanism identified via multi-model systems.
Wang W; Zhao M; Wang Y; Liu J; Wu J; Kang G; Peng S
Mol Biosyst; 2011 Mar; 7(3):766-72. PubMed ID: 21116565
[TBL] [Abstract][Full Text] [Related]
2. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3).
Li Y; Wang W; Xu X; Sun S; Qu XJ
Biomed Pharmacother; 2015 Feb; 69():125-32. PubMed ID: 25661348
[TBL] [Abstract][Full Text] [Related]
3. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3.
Li Y; Wang W; Xu X; Sun S; Xu X; Qu XJ
Biomed Res Int; 2015; 2015():491205. PubMed ID: 25961022
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
Wang LL; Li JJ; Zheng ZB; Liu HY; Du GJ; Li S
Eur J Pharmacol; 2004 Oct; 502(1-2):1-10. PubMed ID: 15464084
[TBL] [Abstract][Full Text] [Related]
5. Novel N-(3-carboxyl-9-benzyl-beta-carboline-1-yl)ethylamino acids: synthesis, anti-tumor evaluation, intercalating determination, 3D QSAR analysis and docking investigation.
Wu J; Zhao M; Qian K; Lee KH; Morris-Natschke S; Peng S
Eur J Med Chem; 2009 Oct; 44(10):4153-61. PubMed ID: 19535177
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation.
Jiang Y; Jiang X; Law K; Chen Y; Gu J; Zhang W; Xin H; Sha X; Fang X
Int J Pharm; 2011 Aug; 415(1-2):252-8. PubMed ID: 21645594
[TBL] [Abstract][Full Text] [Related]
7. A class of novel carboline intercalators: Their synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and 3D QSAR analysis.
Wu J; Li C; Zhao M; Wang W; Wang Y; Peng S
Bioorg Med Chem; 2010 Sep; 18(17):6220-9. PubMed ID: 20692841
[TBL] [Abstract][Full Text] [Related]
8.
Wu J; Zhao M; Wang Y; Wang Y; Zhu H; Zhao S; Gui L; Zhang X; Peng S
Drug Des Devel Ther; 2017; 11():225-239. PubMed ID: 28176928
[TBL] [Abstract][Full Text] [Related]
9. A class of Trp-Trp-AA-OBzl: Synthesis, in vitro anti-proliferation/in vivo anti-tumor evaluation, intercalation-mechanism investigation and 3D QSAR analysis.
Zhang X; Yang Y; Zhao M; Liu L; Zheng M; Wang Y; Wu J; Peng S
Eur J Med Chem; 2011 Aug; 46(8):3410-9. PubMed ID: 21620529
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations, phosphorylated mitogen-activated protein kinase kinase 1 inhibition, and efficacy.
Wong H; Belvin M; Herter S; Hoeflich KP; Murray LJ; Wong L; Choo EF
J Pharmacol Exp Ther; 2009 Apr; 329(1):360-7. PubMed ID: 19147858
[TBL] [Abstract][Full Text] [Related]
11. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
12. Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
Zhang Q; Pan J; Zheng RL; Wang Q
Pharmazie; 2005 May; 60(5):378-82. PubMed ID: 15918590
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
[TBL] [Abstract][Full Text] [Related]
14. 5-(Bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA): showing a strategy of designing drug to block lung metastasis of tumors.
Gan T; Wang Y; Zhao M; Wu J; Yang J; Peng S
Drug Des Devel Ther; 2016; 10():711-21. PubMed ID: 26937173
[TBL] [Abstract][Full Text] [Related]
15. Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II.
Bal C; Baldeyrou B; Moz F; Lansiaux A; Colson P; Kraus-Berthier L; Léonce S; Pierré A; Boussard MF; Rousseau A; Wierzbicki M; Bailly C
Biochem Pharmacol; 2004 Nov; 68(10):1911-22. PubMed ID: 15476662
[TBL] [Abstract][Full Text] [Related]
16. A class of novel N-isoquinoline-3-carbonyl-L-amino acid benzylesters: synthesis, anti-tumor evaluation and 3D QSAR analysis.
Zheng M; Yang Y; Zhao M; Zhang X; Wu J; Chen G; Peng L; Wang Y; Peng S
Eur J Med Chem; 2011 May; 46(5):1672-81. PubMed ID: 21414693
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, safety, and efficacy of a liposome encapsulated thymidylate synthase inhibitor, OSI-7904L [(S)-2-[5-[(1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric acid] in mice.
Desjardins J; Emerson DL; Colagiovanni DB; Abbott E; Brown EN; Drolet DW
J Pharmacol Exp Ther; 2004 Jun; 309(3):894-902. PubMed ID: 14982966
[TBL] [Abstract][Full Text] [Related]
18. Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxylhex-1-yl]-L-amino acid dichloroplatinates(II) with high anti-tumor activity and low side reaction.
Wang Y; Kang G; Liu J; Zhao M; Wu J; Zhang X; Li Y; Zhong X; Yang Y; Peng S
Metallomics; 2012 May; 4(5):441-7. PubMed ID: 22488043
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
[TBL] [Abstract][Full Text] [Related]
20. Novel N-(3-carboxyl-9-benzyl-carboline-1-yl)ethylamino acids: synthesis, anti-proliferation activity and two-step-course of intercalation with calf thymus DNA.
Wu J; Cui G; Zhao M; Cui C; Peng S
Mol Biosyst; 2007 Dec; 3(12):855-61. PubMed ID: 18000563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
